Digipath Files Provisional Patent for New Discovery in Terpene Technology
11 Mars 2019 - 2:00PM
InvestorsHub NewsWire
Digipath Files Provisional
Patent for New Discovery in Terpene
Technology
Company Looks to Secure
Intellectual Property Rights for Terpene-Based
Pesticide
LAS VEGAS, NV
-- March 11, 2019 -- InvestorsHub NewsWire
-- Digipath, Inc. (OTCQB:
DIGP), a service-oriented
independent testing laboratory, data and media firm focused on the
developing cannabis and hemp markets, is
pleased to announce that it has filed a United States
provisional patent application for
“A METHOD OF
DETERMINING TERPENE-BASED BIOCONTROL AGENTS FOR CANNABIS AND
HEMP.” This application relates
to a method of using natural, plant based, non-toxic compounds
instead of chemical pesticides in cannabis and hemp
cultivation.
Terpenes
are major components of plant derived essential oils and have been
used by humans for thousands of years.
Natural terpenes play a critical role in a
plant’s interaction with its environment, including
repelling pests
and attracting pollinators. Mold presents a difficult problem for many cannabis
cultivators, resulting in a failure rate of approximately
10% for flower harvests in Nevada, with higher failure rates in
California. Mold infections cost cultivators significant money and
time, and present potential health risks for consumers. Synthetic
fungicides also present their own regulatory, economic, and health
risks.
While cannabis growers
represent a small portion of a vast pesticide market, the impact of
noxious pesticides on cannabis crops is significant. With an
average price of cannabis in Nevada of $2,799 per pound according
to the Nevada Department of Taxation, a tainted crop can be
tremendously costly to the cultivator. Through its testing lab
operations in Nevada, Digipath has observed a roughly 1% failure
rate of cannabis flower submitted for testing due to pesticide
issues. Results in neighboring states like California are
significantly worse, upwards of 20% in some areas. And while
Digipath’s efforts are focused on its core market of cannabis, its
science team believes that there are other large agricultural
markets for this technology.
“We sought to take
advantage of the production of terpenes by cannabis plants as
naturally-derived microbial control agents,” offered Cindy Orser,
PhD, Digipath’s Chief Science Officer, “Not only can terpenes be
used to distinguish and categorize cannabis cultivars from one
another, we noticed that certain cultivars fail for mold much more
often than others and it can be tied to their terpene
chemoprofile.”
About Digipath, Inc. & Digipath Labs,
Inc.
Digipath,
Inc. supports the
cannabis industry's best practices for reliable testing, data
acquisition, cannabis education and training, and brings unbiased
cannabis news coverage to the cannabis
industry. Digipath
Labs provides
pharmaceutical-grade analysis and testing to the cannabis industry
to ensure producers, consumers, and patients know exactly what is
in the cannabis they ingest and to help maximize the quality of its
client's products through analysis, research, development, and
standardization.
Digipath Investor Relations & Financial
Media
Integrity Investor
Relations
info@integrityir.com
Toll Free: (888) 216-3595
www.IntegrityIR.com
Information
about Forward-Looking
Statements
This press release contains
"forward-looking statements" that include information relating to
future events. Forward-looking statements should not be read as a
guarantee of future performance or results and will not necessarily
be accurate indications of the times at, or by, which that
performance or those results will be achieved. Forward-looking
statements are based on information available at the time they are
made and/or management's good faith belief as of that time with
respect to future events and are subject to risks and uncertainties
that could cause actual performance or results to differ materially
from those expressed in, or suggested by, the forward-looking
statements. Important factors that could cause these differences
include, but are not limited to: the Company's need for additional
funding, the demand for the Company's products, governmental
regulation of the cannabis industry, the Company's ability to
maintain customer and strategic business relationships, the impact
of competitive products and pricing, growth in targeted markets,
the adequacy of the Company's liquidity and financial strength to
support its growth, and other risks that may be detailed from
time-to-time in the Company's filings with the United States
Securities and Exchange Commission. For a more detailed description
of the risk factors and uncertainties affecting Digipath, please
refer to the Company's recent Securities and Exchange Commission
filings, which are available at www.sec.gov. The Company
undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise.
Digipath (PK) (USOTC:DIGP)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Digipath (PK) (USOTC:DIGP)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Digipath Inc (PK) (OTCMarkets): 0 recent articles
Plus d'articles sur Digipath (QB)